You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CSF-1R

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Positron Emission Tomography, Alzheimer, Neurodegenerative Diseases Trial in Shanghai ([18F]CSF-23)

Recruiting
  • Positron Emission Tomography
  • +2 more
  • [18F]CSF-23
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)

Active, not recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 10, 2023

Assess CSF1R-related Leukoencephalopathy After Stem Cell

Enrolling by invitation
  • CSF1R-related Leukoencephalopathy
  • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Dec 7, 2021

    Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

    Active, not recruiting
    • Sarcoma
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 26, 2022

    Peripheral T Cell Lymphoma Trial in Ann Arbor, Columbus, Madison (Nivolumab, cabiralizumab)

    Active, not recruiting
    Has Results
    • Peripheral T Cell Lymphoma
    • Ann Arbor, Michigan
    • +2 more
    Aug 13, 2021

    Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • (no location specified)
    Jun 27, 2022

    Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

    Active, not recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Jan 5, 2023

    Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

    Completed
    • Colorectal Cancer
    • +3 more
    • Lyon, France
    • +1 more
    Sep 2, 2021

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Edicotinib, Pharmacokinetic Study)

    Terminated
    Has Results
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 1, 2021

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

    Recruiting
    • Acute Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 26, 2022

    Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

    Recruiting
    • Solid Tumor
    • +2 more
    • Los Angeles, California
    • +3 more
    Jul 29, 2021

    Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

    Recruiting
    • Mucopolysaccharidosis Disorders
    • +28 more
    • Stem Cell Transplantation
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 1, 2022

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

    Recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Jun 8, 2022

    Alzheimer, Mild Cognitive Impairment Trial in Cambridge, London, Oxford (JNJ-40346527, Placebo)

    Not yet recruiting
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • Cambridge, United Kingdom
    • +2 more
    Oct 27, 2020

    Healthy Trial in Saint Paul (Low dose Regular Insulin, High dose Regular insulin)

    Recruiting
    • Healthy
    • Low dose Regular Insulin
    • High dose Regular insulin
    • Saint Paul, Minnesota
      HealthPartners Neuroscience Center
    May 23, 2023

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • 3-Dimensional Conformal Radiation Therapy
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 4, 2022

    Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

    Terminated
    Has Results
    • Philadelphia Chromosome Negative
    • +2 more
    • Blinatumomab
    • +11 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 3, 2022

    Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

    Recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +8 more
    • Polatuzumab Vedotin
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 26, 2023

    Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML) Trial in Italy (NMS-03592088)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Chronic Myelomonocytic Leukemia (CMML)
    • Bergamo, BG, Italy
    • +4 more
    Mar 23, 2021

    Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Oct 12, 2022

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

    Active, not recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

    Recruiting
    • Aplastic Anemia
    • +3 more
    • Anti-Thymocyte Globulin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 1, 2021

    Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)

    Active, not recruiting
    Has Results
    • Brain and Central Nervous System Tumors
    • filgrastim
    • +5 more
    • Durham, North Carolina
    • +8 more
    Dec 17, 2021